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Antibiotic susceptibility testing and breakpoint 
determination 
To the Editors: 
Re:  Phillips I .  Clin Microbiol Infect 1995; l(1): 65-6 
O n  behalf of the Susceptibility Testing Working Party 
of the British Society for Antimicrobial Chemotherapy, 
I would like to endorse the views of the President of 
ESCMID in his aim to move to comparable suscepti- 
bility testing within Europe. The initial move to 
develop a reference method is commendable as it avoids 
the imposition of a standard method. The options for 
a reference method will have to be carefully considered 
as different methodologies are more applicable for 
different situations. A reference method, in my 
opinion, will have to be a minimum inhibitory con- 
centration (MIC) determination as a disk-diffusion 
method, by necessity, is based on MICs. I note that 
Professor Phillips suggests a broth-dilution MIC deter- 
mination for a reference procedure. It is our experience 
that agar-dilution procedures are highly flexible and 
often give clearer endpoints and, hence, are more 
reproducible. Both methods are equally open to 
automation. It is possible for two equivalent reference 
methodologies to be investigated. 
It  is my view that, in the UK, there is a need for a 
change from the Stokes methods employed for disk 
testing, an opinion I know to be shared by others. At 
present, work ongoing in my department, involving 
colleagues in France, Belgium and Italy, and using 
different disk-diffusion methodologies, suggests that 
our results are very similar. We have more in common 
than differences among us. Now is the time for possible 
change. 
Richard Wise 
Chairman, BSAC Working Party 
London. UK 
Continuing medical education (CME) credits and 
multiple-choice questions 
To the Editors: 
Re:  Speller et al., Clin Microbiol Infect 1995; l(1): 54-9 
I have read with interest the paper on glycopeptide 
resistance in gram-positive bacteria and completed the 
multiple-choice questions (MCQ) . 
Medical practitioners living in remote areas away 
from centers of medical education may struggle to gain 
sufficient CME credits to maintain accreditation in 
their professional disciplines. Perhaps the M C Q  in your 
journal could be marked according to some arrange- 
ment with the institutions involved in the awarding of 
credits for CME? 
An example of how this can be done is seen in the 
monthly state-of-the-art clinical articles published in 
Clinical Infectious Diseases in the United States. This 
arrangement would reduce the cost of CME while, at 
the same time, increasing the sale of and subscription 
to your journal. 
John Hartley 
Truro, Cornwall, UK 
To Dr Hartley: 
We are pleased that at least one reader has found the 
M C Q  section in the first Continuing Education article 
useful, and we welcome any other comments on the 
format. Subsequent articles in this section will continue 
to include multiple-choice questions. 
The possibility of linking these M C Q  to formal 
schemes of continuing education and accreditation has 
been discussed. The degree of development and the 
details of such systems among the European countries 
vary considerably. We believe that, at the present time, 
we should not link our MCQs to participation in 
particular schemes, but continue to provide answers for 
immediate use in self-assessment. In the future, it is 
hoped that CME and accreditation will be carried out 
on a European basis, possibly with the involvement of 
the European Society of Clinical Microbiology and 
Infectious Diseases. At such a time, Clinical Microbiology 
and Injection will be eager to collaborate on such a 
scheme. 
David C. E. Speller 
Co-Editor 
Risk-factor analysis and diagnostic index for 
Pseudomonas aeruginosa bacteremia 
To the Editors: 
Re:  Gransden et al., Clin Microbiol Infect 1995; l(2): 
119-23 
Dr Gransden and his colleagues identified neutropenia, 
cytotoxic or corticosteroid treatment, male gender, 
acquisition of infection in hospital, detection of 
bacteremia in the intensive care unit, previous or 
current antibiotic treatment and site of infection as risk 
factors for Psendomonas aernginosa bacteremia. O n  the 
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